Top Pharmaceuticals companies in France by EBT Margin
France
# |
Name |
EBT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
35.75%
|
Dec. 31, 2023 | USD 4.54 | 0.83% |
|
France |
|
| 2 |
26.12%
|
Dec. 31, 2023 | USD 39.47 | -3.91% |
|
France |
|
| 3 |
22.87%
|
Dec. 31, 2023 | USD 122.64 | 0.35% |
|
France |
|
| 4 |
16.16%
|
Dec. 31, 2023 | USD 20.08 K | 0.04% |
|
France |
|
| 5 |
15.54%
|
Dec. 31, 2023 | USD 96.09 | -1.23% |
|
France |
|
| 6 |
14.53%
|
Dec. 31, 2023 | USD 71.52 | -1.80% |
|
France |
|
| 7 |
14.45%
|
Dec. 31, 2023 | USD 208.18 | -0.28% |
|
France |
|
| 8 |
11.91%
|
Dec. 31, 2023 | USD 110.89 | -1.59% |
|
France |
|
| 9 |
9.75%
|
Dec. 31, 2023 | USD 3.97 | 0.60% |
|
France |
|
| 10 |
9.50%
|
Dec. 31, 2023 | USD 27.83 | 2.50% |
|
France |
|
| 11 |
6.33%
|
Dec. 31, 2023 | USD 74.26 | 0.89% |
|
France |
|
| 12 |
5.34%
|
Dec. 31, 2023 | USD 26.07 | 0.60% |
|
France |
|
| 13 |
3.87%
|
Dec. 31, 2023 | USD 27.36 | -1.07% |
|
France |
|
| 14 |
3.61%
|
Dec. 31, 2023 | USD 10.08 | 4.45% |
|
France |
|
| 15 |
3.12%
|
June 30, 2024 | USD 23.39 | -1.14% |
|
France |
|
| 16 |
1.14%
|
Dec. 31, 2023 | USD 3.17 | NA |
|
France |
|
| 17 |
1.12%
|
Dec. 31, 2023 | USD 13.50 | -2.38% |
|
France |
|
| 18 |
1.01%
|
June 30, 2024 | USD 3.36 | -0.01% |
|
France |
|
| 19 |
-0.81%
|
June 30, 2024 | USD 12.99 | 0.21% |
|
France |
|
| 20 |
-14.59%
|
Dec. 31, 2023 | USD 1.88 | -0.49% |
|
France |
|
| 21 |
-23.83%
|
Dec. 31, 2023 | USD 3.26 | 2.55% |
|
France |
|
| 22 |
-33.98%
|
Dec. 31, 2023 | USD 2.02 | -2.42% |
|
France |
|
| 23 |
-42.67%
|
Dec. 31, 2023 | USD 2.27 | 11.78% |
|
France |
|
| 24 |
-56.05%
|
Dec. 31, 2023 | USD 2.16 | 6.70% |
|
France |
|
| 25 |
-64.16%
|
Dec. 31, 2023 | USD 2.16 | -2.19% |
|
France |
|
| 26 |
-75.82%
|
Dec. 31, 2023 | USD 1.29 | -1.75% |
|
France |
|
| 27 |
-99.82%
|
Dec. 31, 2023 | USD 3.40 | -0.30% |
|
France |
|
| 28 |
-103.06%
|
Dec. 31, 2023 | USD 4.74 | -2.78% |
|
France |
|
| 29 |
-131.68%
|
Dec. 31, 2023 | USD 3.05 | 0.95% |
|
France |
|
| 30 |
-198.52%
|
Dec. 31, 2023 | USD 1.50 | -9.33% |
|
France |
|
| 31 |
-208.87%
|
March 31, 2024 | USD 16.86 | 0.98% |
|
France |
|
| 32 |
-223.17%
|
Dec. 31, 2023 | USD 2.05 | -2.81% |
|
France |
|
| 33 |
-246.72%
|
Dec. 31, 2023 | USD 0.68 | -1.49% |
|
France |
|
| 34 |
-462.35%
|
Dec. 31, 2023 | USD 4.64 | -14.23% |
|
France |
|
| 35 |
-505.54%
|
Dec. 31, 2023 | USD 1.53 | 0.60% |
|
France |
|
| 36 |
-628.36%
|
Dec. 31, 2023 | USD 2.29 | 4.37% |
|
France |
|
| 37 |
-884.96%
|
Dec. 31, 2023 | USD 8.53 | 3.61% |
|
France |
|
| 38 |
-984.19%
|
Dec. 31, 2023 | USD 6.08 | 1.81% |
|
France |
|
| 39 |
-1,042.70%
|
Dec. 31, 2023 | USD 6.91 | 0.46% |
|
France |
|
| 40 |
-1,291.09%
|
Dec. 31, 2023 | USD 1.42 | -0.83% |
|
France |
|
| 41 |
-1,402.22%
|
Dec. 31, 2023 | USD 4.25 | 1.59% |
|
France |
|
| 42 |
-1,803.52%
|
Dec. 31, 2023 | USD 0.96 | -6.39% |
|
France |
|
| 43 |
-1,865.31%
|
Dec. 31, 2023 | USD 1.82 | 1.18% |
|
France |
|
| 44 |
-3,294.37%
|
Dec. 31, 2023 | USD 6.25 | -0.54% |
|
France |
|
| 45 |
-7,934.48%
|
Dec. 31, 2023 | USD 2.22 | -0.32% |
|
France |
|
| 46 |
-15,425.70%
|
Dec. 31, 2023 | USD 1.74 | -2.29% |
|
France |
Frequently Asked Questions
-
Which Pharmaceuticals company in France has the highest EBT Margin ?
The Pharmaceuticals company in France with the highest EBT Margin is Euromedis Groupe (Paris Stock Exchange: ALEMG.PA) at 35.75%.
-
Which Pharmaceuticals company in France has the lowest EBT Margin ?
The Pharmaceuticals company in France with the lowest EBT Margin is Cellectis S.A. (Paris Stock Exchange: ALCLS.PA) at -15,425.70%.
-
What are the top 10 Pharmaceuticals companies in France by EBT Margin ?
The top 10 Pharmaceuticals companies in France by EBT Margin are Euromedis Groupe, Equasens Société anonyme, Ipsen S.A., Eurofins-Cerep SA, Sanofi, Vetoquinol SA, Sartorius Stedim Biotech S.A., bioMérieux S.A., genOway Société anonyme and Boiron SA.
-
What are the bottom 10 Pharmaceuticals companies in France by EBT Margin ?
The bottom 10 Pharmaceuticals companies in France by EBT Margin are Cellectis S.A., Crossject Société Anonyme, ABIVAX Société Anonyme, PHAXIAM Therapeutics S.A., Neovacs S.A., Predilife S.A., Affluent Medical SA, OSE Immunotherapeutics SA, Adocia SA and MaaT Pharma SA.